[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346770-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346770-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enhancing-cervical-cancer-screening-uptake-through-self-sampling-for-hpv-dna-testing-insights-and-results-from-implementing-in-routine-hiv-clinics-serving-women-living-with-hiv-in-nairobi-kenya-20212024","Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing - insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021–2024","","Cervical cancer screening remains low in sub-Saharan Africa, where women living with HIV face markedly higher risk than HIV-uninfected women. Self-sampling for HPV DNA testing may reduce stigma, fear, and discomfort, yet Kenya-specific implementation evidence is limited. The study assessed feasibility and adoption of integrating self-sampling in routine HIV clinics in Nairobi between 2021 and 2024, using Kenya EMR data from 60 facilities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enhancing-cervical-cancer-screening-uptake-through-self-sampling-for-hpv-dna-testing-insights-and-results-from-implementing-in-routine-hiv-clinics-serving-women-living-with-hiv-in-nairobi-kenya-20212024/346770/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enhancing-cervical-cancer-screening-uptake-through-self-sampling-for-hpv-dna-testing-insights-and-results-from-implementing-in-routine-hiv-clinics-serving-women-living-with-hiv-in-nairobi-kenya-20212024/346770.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why focus on HPV DNA self-sampling for cervical cancer screening?","Question",{"text":63,"@type":64},"Self-sampling for HPV DNA testing offers an alternative to VIA and can reduce stigma, fear, and discomfort, potentially improving participation. The study evaluates its implementation in Kenyan HIV clinics where evidence has been limited.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study conducted from 2021 to 2024?",{"text":68,"@type":64},"HIV-infected women aged 25 and over attending comprehensive care clinics in Nairobi were offered self-sampling for HPV DNA testing. Data were abstracted from Kenya electronic medical records across 60 health facilities in Nairobi County.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key outcomes for screening uptake and HPV positivity?",{"text":72,"@type":64},"HPV DNA self-sampling accounted for 48.6% of cervical cancer screening tests. Among 14,227 women screened, 21.9% were HPV positive, and integration increased overall screening rates and demand, reaching many first-time screened women.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346770,1790472239,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Wangusi etal. BMC Cancer (2026) 26:410 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15771-3](https://doi.org/10.1186/s12885-026-15771-3)  \nRESEARCH Open Access  \nEnhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021–2024  \nRebeccah Wangusi1*, Evelyn Ngugi2, Sam Wafula1, Patrick Awuor1, Emmah Momanyi 1, Rose Nyaboke1,  \nViolet Makokha1, Joshua Orawo1, Wilson Kariuki1, Cyrus Gichaga1, Anthony Kiplagat3, Caroline Ngunu3, Robert Rianga3, Immaculate Mutisya2, Kenneth Masamaro2, Frank Basiye2, Christina Mwachari1, Stella Njuguna2, Abraham Katana2, Caroline Ngeno1, Emily Koech1 and Ann Chao4  \nAbstract  \nBackground In sub-Saharan Africa (SSA), only 14% of women aged 30 to 49 years have been screened for cervical cancer even though the region accounts for a quarter of global cervical cancer deaths. Women living with HIV are six times more likely to develop cervical cancer as compared to HIV-uninfected women in SSA. Unlike traditional screening methods such as Visual Inspection with Acetic Acid (VIA), the self-sampling for Human Papillomavirus (HPV) DNA testing offers a promising alternative as it reduces stigma, fear, and discomfort associated with cervical screening. However, evidence on its implementation in Kenya is limited. This study examined the feasibility and adoption of integrating self-sampling for HPV DNA testing in routine HIV clinics.  \nMethods Between 2021 and 2024, HIV-infected women, aged 25 years and over, attending comprehensive care clinics in Nairobi, Kenya, were offered cervical cancer screening using self-sampling for HPV DNA testing. Data were abstracted from the Kenya electronic medical records (Kenya EMR) across 60 health facilities in Nairobi County. We present results, summary characteristics of the clients, and factors associated with testing HPV positive using selfsampling for HPV DNA testing.  \nResults HPV DNA self-sampling accounted for 48 . 6% of cervical cancer screening tests. Of 14,227 women screened using self-sampling for HPV DNA testing, 3111 (21 . 9%) were HPV positive. Nearly half of the women who tested HPV positive (n = 1540; 49 . 6%) were eligible for rescreening using VIA; rescreening results showed that 133 (8 . 6%) were VIA positive. HPV genotyping showed HPV 16 and 18 positivity were 13. 1% and 17. 8%, respectively, with predominance of other high-risk types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) at 66. 6% positivity. HPV positivity was associated  \n*Correspondence: RebeccahWangusi[rwangusi@cihebkenya.org](rwangusi@cihebkenya.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWangusi et al. BMC Cancer (2026) 26:410 Page 2 of 12  \nwith shorter duration on ART. Women who reported","cbCailhfJsCe0UDR","https://ap.wps.com/l/cbCailhfJsCe0UDR","pdf",2688920,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"Why focus on HPV DNA self-sampling for cervical cancer screening?\",\"answer\":\"Self-sampling for HPV DNA testing offers an alternative to VIA and can reduce stigma, fear, and discomfort, potentially improving participation. The study evaluates its implementation in Kenyan HIV clinics where evidence has been limited.\"},{\"question\":\"How was the study conducted from 2021 to 2024?\",\"answer\":\"HIV-infected women aged 25 and over attending comprehensive care clinics in Nairobi were offered self-sampling for HPV DNA testing. Data were abstracted from Kenya electronic medical records across 60 health facilities in Nairobi County.\"},{\"question\":\"What were the key outcomes for screening uptake and HPV positivity?\",\"answer\":\"HPV DNA self-sampling accounted for 48.6% of cervical cancer screening tests. Among 14,227 women screened, 21.9% were HPV positive, and integration increased overall screening rates and demand, reaching many first-time screened women.\"}]","Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing - insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021–2024 | PDF",1790062673,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a43dc3e5bf5376169f43c066c28629f.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b7a8dabae771901115ab09eec89c544.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/619d3944b047da9ddb5704188ddaa48d.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8df89ea0e43c1da612499dd39c129ea1.webp",980,1306]